ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Pennsylvania » Geriatric Medicine

Top Geriatric Medicine Prescribers in Pennsylvania

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ARMAND FORMICA DO

Geriatric Medicine

1,233

$49K

293
232 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $50

DONNA RAZIANO MD MBA

Geriatric Medicine

10,982

$558

275
251 are 65+

14%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

RUSSELL RENTLER MD

Geriatric Medicine

7,196

$329K

269
258 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

GERARD MILLER M.D.

Geriatric Medicine

7,330

$479K

268
252 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

CATHERINE CLARKE M.D.

Geriatric Medicine

4,209

$296K

261
237 are 65+

6%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $50

JOHN HARETOS M.D.

Geriatric Medicine

5,159

$390K

260
219 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$76
Average prescription price

Avg: $50

SHADAB KALIM M.D.

Geriatric Medicine

3,980

$190K

260
92 are 65+

9%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $50

MARY MUSUKU M.D

Geriatric Medicine

5,549

$275K

257
198 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

ROBERT GORDON MD

Geriatric Medicine

14,092

$933K

249
241 are 65+

24%
patients receiving schedule two controlled substances

Avg: 14%

5%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$66
Average prescription price

Avg: $50

ADRIAN VISOIU MD

Geriatric Medicine

3,489

$198K

246
239 are 65+

15%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $50

MICHAEL GLUCK MD

Geriatric Medicine

4,118

$440K

236
199 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

16%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

35%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $50

EMILY JAFFE MD

Geriatric Medicine

17,632

$3,749

236
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

20%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $50

DOROTHY CANDIB MD

Geriatric Medicine

7,265

$360K

235
234 are 65+

42%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

WARD BECKER M.D.

Geriatric Medicine

8,877

$415K

234
230 are 65+

18%
patients receiving schedule two controlled substances

Avg: 14%

9%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

WILLIAM ZIRKER MD

Geriatric Medicine

7,219

$372K

223
203 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

NAMITA AHUJA MD

Geriatric Medicine

6,440

$299K

220
212 are 65+

20%
patients receiving schedule two controlled substances

Avg: 14%

14%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

LYNSEY BRANDT MD

Geriatric Medicine

3,297

$167K

217
214 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

DEBORAH KAHN MD

Geriatric Medicine

4,557

$296K

212
197 are 65+

11%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $50

JOEL BETESH MD

Geriatric Medicine

3,175

$164K

208
169 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

8%
patients receiving schedule three controlled substances

Avg: 6%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $50

KATHLEEN REYES D.O.

Geriatric Medicine

3,196

$128K

199
165 are 65+

13%
patients receiving schedule two controlled substances

Avg: 14%

11%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $50

ANDREA FOX M.D.

Geriatric Medicine

3,157

$139K

196
136 are 65+

7%
patients receiving schedule two controlled substances

Avg: 14%

6%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $50

KAREN GARDNER D.O.

Geriatric Medicine

3,065

$185K

194
169 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

IBIYONU LAWRENCE MD

Geriatric Medicine

3,858

$191K

194
141 are 65+

8%
patients receiving schedule two controlled substances

Avg: 14%

12%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

ROBERT FURIA MD

Geriatric Medicine

6,116

$326K

187
168 are 65+

19%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $50

BRUCE SILVER MD

Geriatric Medicine

4,916

$245K

180
171 are 65+

21%
patients receiving schedule two controlled substances

Avg: 14%

0%
patients receiving schedule three controlled substances

Avg: 6%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank